Building Pillars of Knowledge in Supportive Care: Focus on CINV

MEDIA:

Audio/slides with interactive questions. Live Faculty Q&A. Printable PDF also available.

TARGET AUDIENCE
The educational series is intended for nurses, pharmacists and others with clinical, research, and management interests in CINV treatment.

STATEMENT OF NEED
Despite evidence showing that chemotherapy-induced nausea and vomiting (CINV) can be prevented in most patients receiving emetogenic chemotherapy, an estimated 70% to 80% continue to experience symptoms.  Inadequately controlled CINV can also result in diminished adherence to chemotherapy treatment or delays in and/or withdrawal from potentially beneficial or curative anticancer therapy. In fact, more than 90% of patients who experienced both acute and delayed CINV reported that it had an impact on their daily life, according to a recent study of patients who received cisplatin-based therapy.

EDUCATIONAL OBJECTIVES
On completion of this activity, participants should be able to:

• Describe recent advances in the treatment of cancer patients with chemotherapy-induced nausea and vomiting (CINV)
• Outline key barriers and challenges that impact the supportive care of patients with CINV
• Examine strategies for achieving optimal control of CINV, based on recent evidence-based data and updated clinical practice guidelines

AGENDA:

• Introduction (5 minutes)
• Treatment of CINV: Pharmacologic Agents / Recent Advances (15 minutes)
• Key Barriers and Challenges in the Management of CINV (15 minutes)
• “Solve” clinical case studies based on key clinical evidence and practice guidelines (10 minutes)
• Live faculty Q& A (10 minutes)
• Evaluation and posttest (5 minutes)

FACULTY
Regina Cunningham, PhD, RN, AOCN
Senior Director Oncology
The Tisch Cancer Institute
Mount Sinai Medical Center
New York, NY

Dr. Cunningham has disclosed that she serves on speakers’ bureau for Merck.

Shawna Kraft, PharmD, BCOP
Clinical Pharmacist/Oncology
Adjunct Clinical Assistant Professor
Department of Pharmacy Services
College of Pharmacy
University of Michigan
Ann Arbor, MI

Dr. Kraft has no financial relationships to disclose relating to the content of this activity.

The planners and managers have no financial or other relationship to products or devices with commercial interests related to the content of this CE activity.

INSTRUCTIONS
To receive a statement of credit, you must:

• Review the full content of the activity
• Complete the questions within the activity
• Complete the evaluation at the end of the activity.

ACCREDITATION STATEMENTS

PHARMACY

Creative Educational Concepts, Inc. (CEC) is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.

This knowledge-based activity has been assigned ACPE # 0245-0000-11-019-H01-P and will award 1.0 contact hour (0.10 CEUs) of continuing pharmacy education credit. CEC complies with the Criteria for Quality for continuing education programming.

NURSING

Creative Educational Concepts, Inc. (CEC) is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center's Commission on Accreditation.

CEC provides this activity for 1.0 contact hour.

Learners are advised that accredited status does not imply endorsement by the provider or ANCC of any commercial products displayed in conjunction with an activity.

Your statement of credit will be issued immediately upon successful completion of the posttest and evaluation form.

FEE
This activity is complimentary.

DISCLOSURE DECLARATION
It is the policy of CEC, Astute CE and COE to ensure independence, balance, objectivity, scientific rigor, and integrity in their continuing education activities.

Those involved in the development of this continuing education activity have made all reasonable efforts to ensure that information contained herein is accurate in accordance with the latest available scientific knowledge at the time of accreditation of this continuing education activity. Information regarding drugs (e.g., their administration, dosages, contraindications, adverse reactions, interactions, special warnings, and precautions) and drug delivery systems is subject to change, however, and the reader is advised to check the manufacturer's package insert for information concerning recommended dosage and potential problems or cautions prior to dispensing or administering the drug or using the drug delivery systems.

Fair balance is achieved through ongoing and thorough review of all presentation materials produced by faculty, and all educational and advertising materials produced by supporting organizations, prior to educational offerings. Approval of credit for this continuing education activity does not imply endorsement by CEC for any product or manufacturer identified.

UNLABELED USE DISCLOSURE
This activity may include discussions of products or devices that are not currently approved for use by the Food and Drug Administration (FDA), or are currently investigational.

This activity is jointly sponsored by Creative Educational Concepts, Inc., Center of Excellence Media, LLC, and Astute Continuing Education, LLC.
       

SUPPORTING ORGANIZATION:
This activity is supported by an independent educational grant from Eisai, Inc.

REQUIRED COMPUTER HARDWARE/SOFTWARE: